| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9766 |
| Human Intestinal Absorption | HIA+ | 0.9907 |
| Caco-2 Permeability | Caco2+ | 0.7407 |
| P-glycoprotein Substrate | Non-substrate | 0.8420 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9751 |
| Non-inhibitor | 0.9839 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9158 |
| Distribution |
| Subcellular localization | Lysosome | 0.6352 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7952 |
| CYP450 2D6 Substrate | Non-substrate | 0.8462 |
| CYP450 3A4 Substrate | Non-substrate | 0.7982 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9103 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9626 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9758 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9783 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9862 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9175 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9482 |
| Non-inhibitor | 0.9738 |
| AMES Toxicity | Non AMES toxic | 0.9732 |
| Carcinogens | Carcinogens | 0.6995 |
| Fish Toxicity | Low FHMT | 0.6105 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7136 |
| Honey Bee Toxicity | High HBT | 0.8235 |
| Biodegradation | Ready biodegradable | 0.6385 |
| Acute Oral Toxicity | III | 0.7149 |
| Carcinogenicity (Three-class) | Non-required | 0.4942 |